...
nby-img

NovaBay Pharmaceuticals Inc, Common Stock

NBY

ASQ

$0.532

-$0.06

(-10.19%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.89M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
168.22K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.73
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.36 L
$10.15 H
$0.532

About NovaBay Pharmaceuticals Inc, Common Stock

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameNBYSectorS&P500
1-Week Return2.9%-1.85%-0.15%
1-Month Return-16.52%-3.48%0.71%
3-Month Return29.08%-7.47%9.92%
6-Month Return-79.13%-1.95%12.57%
1-Year Return-94.04%8.39%30.57%
3-Year Return-99.91%7.07%28.07%
5-Year Return-99.92%44.2%92.45%
10-Year Return-100%106.89%197.42%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue6.60M9.93M8.42M14.40M14.73M[{"date":"2019-12-31","value":44.81,"profit":true},{"date":"2020-12-31","value":67.46,"profit":true},{"date":"2021-12-31","value":57.18,"profit":true},{"date":"2022-12-31","value":97.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue1.74M3.97M2.78M6.62M6.83M[{"date":"2019-12-31","value":25.44,"profit":true},{"date":"2020-12-31","value":58.12,"profit":true},{"date":"2021-12-31","value":40.64,"profit":true},{"date":"2022-12-31","value":96.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit4.86M5.96M5.64M7.78M7.89M[{"date":"2019-12-31","value":61.57,"profit":true},{"date":"2020-12-31","value":75.54,"profit":true},{"date":"2021-12-31","value":71.5,"profit":true},{"date":"2022-12-31","value":98.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin73.66%60.04%67.03%54.02%53.61%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":81.5,"profit":true},{"date":"2021-12-31","value":91,"profit":true},{"date":"2022-12-31","value":73.33,"profit":true},{"date":"2023-12-31","value":72.78,"profit":true}]
Operating Expenses14.26M12.39M14.51M15.46M12.90M[{"date":"2019-12-31","value":92.24,"profit":true},{"date":"2020-12-31","value":80.14,"profit":true},{"date":"2021-12-31","value":93.83,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.42,"profit":true}]
Operating Income(9.40M)(6.43M)(8.86M)(7.68M)(5.00M)[{"date":"2019-12-31","value":-940000000,"profit":false},{"date":"2020-12-31","value":-642600000,"profit":false},{"date":"2021-12-31","value":-886200000,"profit":false},{"date":"2022-12-31","value":-768000000,"profit":false},{"date":"2023-12-31","value":-500300000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(9.65M)(11.03M)(5.82M)(10.61M)(9.64M)[{"date":"2019-12-31","value":-965200000,"profit":false},{"date":"2020-12-31","value":-1103400000,"profit":false},{"date":"2021-12-31","value":-582400000,"profit":false},{"date":"2022-12-31","value":-1060800000,"profit":false},{"date":"2023-12-31","value":-964000000,"profit":false}]
Income Taxes6.00K5.00K(4.62M)(3.81M)35.10K[{"date":"2019-12-31","value":17.09,"profit":true},{"date":"2020-12-31","value":14.24,"profit":true},{"date":"2021-12-31","value":-13146.28,"profit":false},{"date":"2022-12-31","value":-10850.31,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(9.66M)(11.04M)(5.82M)(10.61M)(13.74M)[{"date":"2019-12-31","value":-965800000,"profit":false},{"date":"2020-12-31","value":-1103900000,"profit":false},{"date":"2021-12-31","value":-582400000,"profit":false},{"date":"2022-12-31","value":-1060800000,"profit":false},{"date":"2023-12-31","value":-1373800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(10.49M)(11.04M)(6.56M)(16.27M)(9.64M)[{"date":"2019-12-31","value":-1048700000,"profit":false},{"date":"2020-12-31","value":-1103900000,"profit":false},{"date":"2021-12-31","value":-655900000,"profit":false},{"date":"2022-12-31","value":-1626500000,"profit":false},{"date":"2023-12-31","value":-964000000,"profit":false}]
EPS (Diluted)(16.80)(11.55)(5.25)(7.43)(3.19)[{"date":"2019-12-31","value":-1680,"profit":false},{"date":"2020-12-31","value":-1155,"profit":false},{"date":"2021-12-31","value":-525,"profit":false},{"date":"2022-12-31","value":-743,"profit":false},{"date":"2023-12-31","value":-319,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NBY
Cash Ratio 0.39
Current Ratio 1.15
Quick Ratio 0.91

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NBY
ROA (LTM) -38.67%
ROE (LTM) -263.83%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NBY
Debt Ratio Lower is generally better. Negative is bad. 0.72
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.28

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NBY
Trailing PE NM
Forward PE NM
P/S (TTM) 0.22
P/B 2.71
Price/FCF NM
EV/R 0.24
EV/Ebitda NM
PEG NM

FAQs

What is NovaBay Pharmaceuticals Inc share price today?

NovaBay Pharmaceuticals Inc (NBY) share price today is $0.532

Can Indians buy NovaBay Pharmaceuticals Inc shares?

Yes, Indians can buy shares of NovaBay Pharmaceuticals Inc (NBY) on Vested. To buy NovaBay Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NBY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of NovaBay Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of NovaBay Pharmaceuticals Inc (NBY) via the Vested app. You can start investing in NovaBay Pharmaceuticals Inc (NBY) with a minimum investment of $1.

How to invest in NovaBay Pharmaceuticals Inc shares from India?

You can invest in shares of NovaBay Pharmaceuticals Inc (NBY) via Vested in three simple steps:

  • Click on Sign Up or Invest in NBY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in NovaBay Pharmaceuticals Inc shares
What is NovaBay Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of NovaBay Pharmaceuticals Inc (NBY) is $10.15. The 52-week low price of NovaBay Pharmaceuticals Inc (NBY) is $0.36.

What is NovaBay Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of NovaBay Pharmaceuticals Inc (NBY) is

What is NovaBay Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of NovaBay Pharmaceuticals Inc (NBY) is 2.71

What is NovaBay Pharmaceuticals Inc dividend yield?

The dividend yield of NovaBay Pharmaceuticals Inc (NBY) is 0.00%

What is the Market Cap of NovaBay Pharmaceuticals Inc?

The market capitalization of NovaBay Pharmaceuticals Inc (NBY) is $2.89M

What is NovaBay Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of NovaBay Pharmaceuticals Inc is NBY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top